Kantonsspital St.Gallen


Stephan Brand, Claudia Krieger Grübel & Jolijn Smolders

abstract A Multicenter, Randomized, Double-Blind,
Placebo-Controlled Induction Study to Evaluate the
Efficacy and Safety of Upadacitinib (ABT-494) in
Subjects with Moderately to Severely Active
Ulcerative Colitis
type of project clinical studies
status completed
start of project 2019
end of project 2020
responsible person Dr. Michael Sulz